1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/64826
Full metadata record
DC FieldValueLanguage
dc.creatorLarissa Aparecida Corrêavieirapt_BR
dc.creatorAmanda Gomes de Menêsespt_BR
dc.creatorPriscila de Sousa Maggi Bontempopt_BR
dc.creatorGiovana Paula Rezende Siminopt_BR
dc.creatorElaine Barros Ferreirapt_BR
dc.creatorEliete Neves da Silva Guerrapt_BR
dc.creatorPaula Elaine Diniz Dos Reispt_BR
dc.date.accessioned2024-02-27T20:38:28Z-
dc.date.available2024-02-27T20:38:28Z-
dc.date.issued2022-
dc.citation.volume56pt_BR
dc.citation.issuee20220173pt_BR
dc.citation.spage1pt_BR
dc.citation.epage9pt_BR
dc.identifier.doi10.1590/1980-220x-reeusp-2022-0173enpt_BR
dc.identifier.issn1980220Xpt_BR
dc.identifier.urihttp://hdl.handle.net/1843/64826-
dc.description.resumoObjective: To analyze the incidence, dose of occurrence, grade, severity, and associated risk factors for the development of radiodermatitis, by area of the irradiated breast, in women with breast cancer, during hypofractionated radiotherapy. Method: Observational, prospective, and longitudinal study, according to the guidelines of the Strengthening the Reporting of Observational studies in Epidemiology, carried out between May 2019 and May 2021. Results:A total of 104 women participated in the study, and 73.1% (95%CI: 64–82) developed signs of radiodermatitis during treatment. The majority (63.5%, 95%CI: 54–73) developed erythema in the axillary region with about 36.5 Grays. Women with large breasts and statin users are more likely to develop radiodermatitis. However, women with Phototype III skin color classification (light brown skin) are less likely to develop radiodermatitis, with skin color being a protective factor. Conclusion: The incidence of radiodermatitis in women with breast cancer during hypofractionated radiotherapy is significant. Therefore, the development of protocols for the management of this radiotoxicity is suggested, considering the cumulative dose and associated risk factorspt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentENF - DEPARTAMENTO DE ENFERMAGEM BÁSICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofRevista da Escola de Enfermagem da USP-
dc.rightsAcesso Abertopt_BR
dc.subjectRadiodermatitispt_BR
dc.subjectRadiotherapypt_BR
dc.subjectBreast Neoplasmspt_BR
dc.subjectOncologypt_BR
dc.subjectNursingpt_BR
dc.subjectRadiation Dose Hypofractionationpt_BR
dc.subject.otherRadiodermatitispt_BR
dc.subject.otherRadiotherapypt_BR
dc.subject.otherBreast Neoplasmspt_BR
dc.subject.otherMedical Oncologypt_BR
dc.subject.otherNursingpt_BR
dc.subject.otherRadiation Dose Hypofractionationpt_BR
dc.titleIncidence of radiodermatitis in breast cancer patients during hypofractionated radiotherapypt_BR
dc.title.alternativencidencia de radiodermatitis en pacientes con cáncer de mama durante la radioterapia hipofraccionadapt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://doi.org/10.1590/1980-220X-REEUSP-2022-0173enpt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Incidence of radiodermatitis in breast cancer patients pdfa.pdf4.12 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.